Lusutrombopag for thrombocytopenia in Chinese patients with chronic liver disease undergoing invasive procedures

PURPOSE: Probing efficacy and safety of lusutrombopag in Chinese chronic liver disease (CLD) and severe thrombocytopenia (PLT < 50 × 10(9)/L) patients undergoing elective invasive procedures. METHODS: In this double-blind, parallel-group phase 3 study, 66 patients with CLD and severe thrombocytop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Zhenbin, Wu, Hong, Zeng, Yongyi, Kuang, Ming, Yang, Wei, Meng, Zhiqiang, Chen, Yajin, Hao, Chunyi, Zou, Shubing, Sun, Huichuan, Liu, Chang, Lin, Kecan, Shi, Guoming, Wang, Xiaoying, Fu, Xiutao, Chen, Rongxin, Chen, Yi, Liang, Ruifang, Kano, Takeshi, Pan, Huiyan, Yang, Suna, Fan, Jia, Zhou, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895009/
https://www.ncbi.nlm.nih.gov/pubmed/36258065
http://dx.doi.org/10.1007/s12072-022-10421-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9895009/
https://www.ncbi.nlm.nih.gov/pubmed/36258065
http://dx.doi.org/10.1007/s12072-022-10421-9

Ejemplares similares